propoxyphene Darvon withdrawn
Selected indexed studies
- Synthetic opioids and arrhythmia risk: a new paradigm? (Expert Opin Pharmacother, 2012) [PMID:22770657]
- Propoxyphene and the risk of out-of-hospital death. (Pharmacoepidemiol Drug Saf, 2013) [PMID:23408551]
- cardioToxCSM: A Web Server for Predicting Cardiotoxicity of Small Molecules. (J Chem Inf Model, 2022) [PMID:36219164]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- cardioToxCSM: A Web Server for Predicting Cardiotoxicity of Small Molecules. (2022) pubmed
- Synthetic opioids and arrhythmia risk: a new paradigm? (2012) pubmed
- Propoxyphene and the risk of out-of-hospital death. (2013) pubmed
- Urine drug testing of chronic pain patients. V. Prevalence of propoxyphene following its withdrawal from the United States market. (2013) pubmed
- Pharmacokinetics of common analgesics, anti-inflammatories and antipyretics in children. (1989) pubmed
- QTc interval prolongation by d-propoxyphene: what about other analgesics? (2012) pubmed
- Changing Trends in Opioid Use Among Patients With Rheumatoid Arthritis in the United States. (2017) pubmed
- A trend analysis of laboratory positive propoxyphene workplace urine drug screens before and after the product recall. (2015) pubmed
- Use of analgesics in France, following dextropropoxyphene withdrawal. (2018) pubmed
- Rates of opioid dispensing and overdose after introduction of abuse-deterrent extended-release oxycodone and withdrawal of propoxyphene. (2015) pubmed